248 related articles for article (PubMed ID: 17544419)
1. Alterations in sperm motility after acute oral administration of sildenafil or tadalafil in young, infertile men.
Pomara G; Morelli G; Canale D; Turchi P; Caglieresi C; Moschini C; Liguori G; Selli C; Macchia E; Martino E; Francesca F
Fertil Steril; 2007 Oct; 88(4):860-5. PubMed ID: 17544419
[TBL] [Abstract][Full Text] [Related]
2. Effect of acute in vivo sildenafil citrate and in vitro 8-bromo-cGMP treatments on semen parameters and sperm function.
du Plessis SS; de Jongh PS; Franken DR
Fertil Steril; 2004 Apr; 81(4):1026-33. PubMed ID: 15066459
[TBL] [Abstract][Full Text] [Related]
3. In vitro sildenafil citrate use as a sperm motility stimulant.
Mostafa T
Fertil Steril; 2007 Oct; 88(4):994-6. PubMed ID: 17316632
[TBL] [Abstract][Full Text] [Related]
4. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
Ghofrani HA; Voswinckel R; Reichenberger F; Olschewski H; Haredza P; Karadaş B; Schermuly RT; Weissmann N; Seeger W; Grimminger F
J Am Coll Cardiol; 2004 Oct; 44(7):1488-96. PubMed ID: 15464333
[TBL] [Abstract][Full Text] [Related]
5. Tadalafil has no detrimental effect on human spermatogenesis or reproductive hormones.
Hellstrom WJ; Overstreet JW; Yu A; Saikali K; Shen W; Beasley CM; Watkins VS
J Urol; 2003 Sep; 170(3):887-91. PubMed ID: 12913723
[TBL] [Abstract][Full Text] [Related]
6. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.
Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD
Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil.
von Keitz A; Rajfer J; Segal S; Murphy A; Denne J; Costigan T; Lockhart D; Beasley CM; Emmick JT
Eur Urol; 2004 Apr; 45(4):499-507; discussion 507-9. PubMed ID: 15041116
[TBL] [Abstract][Full Text] [Related]
8. Absence of clinically important HERG channel blockade by three compounds that inhibit phosphodiesterase 5--sildenafil, tadalafil, and vardenafil.
Dustan Sarazan R; Crumb WJ; Beasley CM; Emmick JT; Ferguson KM; Strnat CA; Sausen PJ
Eur J Pharmacol; 2004 Oct; 502(3):163-7. PubMed ID: 15476742
[TBL] [Abstract][Full Text] [Related]
9. The cyclic GMP-specific phosphodiesterase inhibitor, sildenafil, stimulates human sperm motility and capacitation but not acrosome reaction.
Lefièvre L; De Lamirande E; Gagnon C
J Androl; 2000; 21(6):929-37. PubMed ID: 11105920
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
Kloner RA
Am J Cardiol; 2005 Dec; 96(12B):42M-46M. PubMed ID: 16387566
[TBL] [Abstract][Full Text] [Related]
11. High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients.
Weeks JL; Zoraghi R; Beasley A; Sekhar KR; Francis SH; Corbin JD
Int J Impot Res; 2005; 17(1):5-9. PubMed ID: 15538396
[TBL] [Abstract][Full Text] [Related]
12. Comparative relaxing effects of sildenafil, vardenafil, and tadalafil in human corpus cavernosum: contribution of endogenous nitric oxide release.
Toque HA; Priviero FB; Teixeira CE; Claudino MA; Baracat JS; Fregonesi A; De Nucci G; Antunes E
Urology; 2009 Jul; 74(1):216-21. PubMed ID: 19371941
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of direct relaxant effect of sildenafil, tadalafil and vardenafil on corpus cavernosum.
Lau LC; Adaikan PG
Eur J Pharmacol; 2006 Jul; 541(3):184-90. PubMed ID: 16777087
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil citrate improves sperm motility but causes a premature acrosome reaction in vitro.
Glenn DR; McVicar CM; McClure N; Lewis SE
Fertil Steril; 2007 May; 87(5):1064-70. PubMed ID: 17335822
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
[TBL] [Abstract][Full Text] [Related]
16. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
[TBL] [Abstract][Full Text] [Related]
17. Effect of acute tadalafil on sperm motility and acrosome reaction: in vitro and in vivo studies.
Yang Y; Ma Y; Yang H; Jin Y; Hu K; Wang HX; Wang YX; Huang YR; Chen B
Andrologia; 2014 May; 46(4):417-22. PubMed ID: 23581543
[TBL] [Abstract][Full Text] [Related]
18. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial.
Balercia G; Buldreghini E; Vignini A; Tiano L; Paggi F; Amoroso S; Ricciardo-Lamonica G; Boscaro M; Lenzi A; Littarru G
Fertil Steril; 2009 May; 91(5):1785-92. PubMed ID: 18395716
[TBL] [Abstract][Full Text] [Related]
19. Tadalafil as an in vitro sperm motility stimulant.
Mostafa T
Andrologia; 2007 Feb; 39(1):12-5. PubMed ID: 17212804
[TBL] [Abstract][Full Text] [Related]
20. Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue.
Uckert S; Sormes M; Kedia G; Scheller F; Knapp WH; Jonas U; Stief CG
Urology; 2008 Mar; 71(3):526-30. PubMed ID: 18342202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
